Is serum Klotho protective against atherosclerosis in patients with type 1 diabetes mellitus?

Klotho deficiency is associated with several metabolic disorders. Two dimensional (2D) longitudinal strain (LS) of left ventricle (LV), carotid artery intima–media thickness (CIMT), flow-mediated dilation (FMD) of brachial artery and epicardial fat thickness (EFT) have been reported to be early predictors of atherosclerosis. We aimed to investigate the relationship between serum Klotho levels and these early predictors of atherosclerosis in patients with type 1 diabetes mellitus (DM). The study included 45 type 1 diabetic patients and 35 controls. Serum Klotho levels were determined by ELISA method. The patient group was also divided into two subgroups according to serum Klotho levels: high (HK) and low Klotho (LK) groups. EFT, CIMT and FMD were measured according to appropriate recommendations. Speckle tracking analysis was performed using the Echopac software. The patient group had significantly lower serum Klotho (p = 0.001), FMD (p < 0.001) and LS of LV (p < 0.001) values, but larger EFT (p < 0.001) and CIMT (p < 0.001) values than controls. LK subgroup had also significantly lower FMD (p < 0.001) and LS of LV (p < 0.001) but larger EFT (p = 0.002) and CIMT (p < 0.001) values than HK subgroup. Serum Klotho may have a protective effect against atherosclerosis and endothelial dysfunction in type 1 DM.